Genmab SG&A Expense (TTM) Trends | YCharts

Genmab A/S (GMAB)

33.60 -0.81 (-2.35%) USD | NASDAQ | Sep 04, 16:00

33.56 -0.04 (-0.12%) Pre-Market: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GMAB.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2001. Start Trial.

Date	Value
June 30, 2026	726.50M
March 31, 2026	667.61M
December 31, 2025	627.09M
September 30, 2025	597.86M
June 30, 2025	577.90M
March 31, 2025	561.09M
December 31, 2024	559.76M
September 30, 2024	515.82M
June 30, 2024	513.98M
March 31, 2024	505.77M
December 31, 2023	478.47M
September 30, 2023	470.08M
June 30, 2023	435.23M
March 31, 2023	404.97M
December 31, 2022	375.67M
September 30, 2022	328.06M
June 30, 2022	285.89M
March 31, 2022	238.14M
December 31, 2021	202.54M
September 30, 2021	160.86M
June 30, 2021	135.12M
March 31, 2021	118.75M
December 31, 2020	101.83M
September 30, 2020	82.10M
June 30, 2020	71.43M

Date	Value
March 31, 2020	56.04M
December 31, 2019	51.19M
September 30, 2019	42.84M
June 30, 2019	39.35M
March 31, 2019	37.22M
December 31, 2018	33.77M
September 30, 2018	31.12M
June 30, 2018	28.41M
March 31, 2018	24.74M
December 31, 2017	22.37M
September 30, 2017	19.57M
June 30, 2017	17.75M
March 31, 2017	16.24M
December 31, 2016	15.22M
September 30, 2016	15.06M
June 30, 2016	14.04M
March 31, 2016	13.82M
December 31, 2015	13.57M
September 30, 2015	14.10M
June 30, 2015	14.50M
March 31, 2015	14.47M
December 31, 2014	14.13M
September 30, 2014	13.96M
June 30, 2014	13.09M
March 31, 2014	12.52M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

AbbVie, Inc.	14.67B
Ascendis Pharma A/S	662.10M
Zealand Pharma A/S	78.53M
Bavarian Nordic A/S	218.74M
Evaxion AS	4.527M